Member Info for Gogetum

Closed at 8000p uncrossing trade price.
Will we see it up 3% or 4% tomorrow?

Strategists at Deutsche Bank described the news from AstraZeneca on Monday as a “big deal,” saying a string of encouraging vaccine developments in recent weeks constituted “an unprecedented victory for science.”

They suggested that emerging markets, most notably Brazil, Mexico, India, and Indonesia, were likely to be the “big beneficiaries” of the AstraZeneca vaccine. That’s because “the cheaper cost of production and distribution of AstraZeneca is especially relevant for lower and middle-income countries,” they said.

AstraZeneca has said it is making “rapid progress” in terms of manufacturing, with a capacity to produce up to 3 billion doses of the vaccine next year.

The U.S. and India have both agreed to procure 500 million doses of the Oxford-AstraZeneca vaccine, according to data compiled by researchers at Duke University’s Global Health Innovation Centre.

The EU has reached a deal to buy 400 million, and the COVAX facility, a global initiative aimed at ensuring equitable access to Covid-19 treatments and vaccines, has ordered 300 million.

Meanwhile, the U.K., Japan, Indonesia, Brazil, and Latin America excluding Brazil have each confirmed orders of at least 100 million doses.

After the big rise on Wednesday some investors understandably will want to realize some of their gains. Did the same myself and sold 50% of my shares yesterday. I still believe that this is a good recovery play, so bought back in again this morning.
Be interesting to see what happens when the NYSE opens.

Still climbing on the New York exchange
https://www.google.com/search?safe=active&biw=1707&bih=803&tbm=fin&ei=2Gu1X_-EEcuZgQau1qLgAg&stick=H4sIAAAAAAAAAONgecRowS3w8sc9YSn9SWtOXmPU5OIKzsgvd80rySypFJLmYoOyBKX4uXj10_UNDdMMjPPS0suTeQB4qFxAPQAAAA&q=NYSE%3A+MFGP&oq=micro+fo&gs_l=finance-immersive.1.1.81l3.6041.21542.0.23766.30.18.4.0.0.0.110.1522.11j5.16.0....0...1c.1.64.finance-immersive..13.13.979.0...0.93KbKzsoRaI#scso=_8Gu1X8vRMPTB8gL1mr-QAw7:0

Like I said yesterday the sliding dollar is not helping GSK
https://www.cnbc.com/2020/11/18/forex-markets-coronavirus-japanese-yen.html

Can't see any point in selling a hot stock at the moment, even though I'm now well into profit. I'll let it run for a few days and then consider selling 50% to balance my portfolio

The strength of Sterling today hit all the Dollar earners

https://www.theguardian.com/society/2020/nov/16/moderna-vaccines-effectiveness-bodes-well-for-oxfordastrazeneca-jab

Success with Moderna vaccine

What's happened?

https://www.dailymail.co.uk/money/markets/article-8948845/New-boss-shake-Standard-Life-Aberdeen.html

Please don't go Tom, you're doing great things for ITV share value. I don't know how you do it but whenever you post your opinion on ITV, the price goes up, so please keep up your good work.
I took the opposite opinion to you a few months ago and invested in ITV believing that it was a good recovery play and now on paper, showing a handsome 16k profit.
I've got my hopes pinned on the Oxford/Astra vaccine being successful, bringing another increase (smaller than the last leap) in the majority of shares prices, including RDSB where like you I also am invested.
Please don't think about shorting ITV shares Tom as it will spoil your Xmas cheer.
Good luck to everyone with their investments and please stay safe in these difficult times.

Pfizer is working on turning the vaccine into a powder formula. In its current form, the vaccine has to be stored at -70C, which poses significant distribution challenges, especially for lower-income countries.
https://www.theguardian.com/business/2020/nov/11/pfizer-chief-sold-56m-dollars-of-shares-on-day-covid-vaccine-was-announced

https://www.telegraph.co.uk/news/2020/11/11/covid-vaccine-race-leading-rushed-announcements-might-not-bring/

Report citing documents obtained by the Wall Street Journal
https://www.dailymail.co.uk/health/article-8873589/FDA-let-AstraZenecas-coronavirus-vaccine-trials-resume-US.html

Brilliantly timed investment from Alchemy. Now we know why the share price was holding up for the past few days when the rest of the market was falling. I had planned on sitting on my investment here for a couple of years in the hope that it could return to approx 150p but I can't complain at a 61% increase on my investment. Think I'll hang around for a possible counter offer.

SAK50. Wrong of you to speculate with your headline 'Brazilian Patient dies from AZN vaccine.'

Reports indicate that the Doctor was not in the group that received the vaccine with sources telling Reuters that if he had been, the trial would have been suspended.

https://www.dailymail.co.uk/health/article-8865039/Volunteer-AstraZenecas-coronavirus-vaccine-trial-dies-Brazil.html

Talking of mergers!
https://www.theguardian.com/business/2020/jun/07/covid-19-vaccine-astrazeneca-approached-gilead-over-possible-merger

205 to sell and 205.1 to buy. Think that's the tightest spread I've ever seen for these shares